Related Experiment Video
Updated: Aug 13, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity
J Y Tang1, J Temsamani, S Agrawal
1Hybridon, Inc., Worcester, MA 01605.
Researchers developed self-stabilized oligonucleotides with hairpin loops, enhancing resistance to degradation and improving in vivo persistence for potential anti-HIV therapies.
Area of Science:
- Molecular Biology
- Biochemistry
- Antiviral Therapeutics
Background:
- Oligodeoxyribonucleotides are crucial in molecular biology and therapeutics.
- Conventional oligonucleotides are susceptible to enzymatic degradation, limiting their in vivo applications.
- Developing more stable oligonucleotide structures is essential for therapeutic efficacy.
Purpose of the Study:
- To design and characterize a novel class of 'self-stabilized' oligonucleotides.
- To evaluate the stability and hybridization properties of these modified oligonucleotides.
- To assess the anti-HIV activity and in vivo pharmacokinetics of self-stabilized oligonucleotides.
Main Methods:
- Design of oligonucleotides with 3' hairpin loop structures.
- Assessment of resistance to degradation by snake venom phosphodiesterase, DNA polymerase I, and fetal bovine serum.
- Hybridization studies using melting temperature, mobility-shift assays, and RNase H cleavage.
- In vitro anti-HIV activity assays.
- Pharmacokinetic and stability studies in murine models.
Main Results:
- Self-stabilized oligonucleotides demonstrated significantly increased resistance to enzymatic degradation.
- The hairpin loop structure did not impede hybridization with complementary nucleic acids.
- Studies showed enhanced in vivo persistence of self-stabilized oligonucleotides compared to linear controls.
- Preliminary anti-HIV activity was observed, correlating with hairpin loop stability.
Conclusions:
- Self-stabilized oligonucleotides represent a promising new class of nucleic acid-based therapeutics.
- Their enhanced stability and preserved hybridization capabilities offer advantages for drug development.
- Further research into self-stabilized oligonucleotides could lead to novel antiviral strategies, particularly against HIV.
More Related Videos
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly